Opinion

Why Heart Attacks Are Hitting Indians Before 40

Heart attacks were once considered a concern for people in their sixties or seventies. Hearing about someone i...

12 May, 2025 | Monday | Views

Medtech

NIT Rourkela designs breakthrough ECG lead system for enhanced diagnosis of atrial arrhythmias

Researchers at National Institute of Technology (NIT) Rourkela, Odisha, have developed an effective upgra...

15 May, 2025 | Thursday | News

Start-Ups

image credit- shutterstock
Three CSIR Labs and Venture Center to host CSIR startup conclave 2025 in Mumbai

The CSIR Startup Conclave 2025, to be held on May 20–21 at the NESCO Center in Mumbai, is a national eve...

18 May, 2025 | Sunday | News

Inside Magazine

25 Transformative Years of BIOSIMILARS

2025 marks 25 years since India first ventured into the biosimilar space. Over the past quarter century, the country has consistently solidified its position as a global leader in biosimilar approvals, with 135 approvals till January 2025. Initially focused on simpler biologics, the field now includes developing and approving complex monoclonal antibodies (mAbs), antibody-drug conjugates (ADCs), a diversified therapeutic focus, and a growing number of innovative players entering the field. As the industry celebrates this silver jubilee, we reflect on the journey that has not only transformed India's biotechnology sector but has also played a pivotal role in making life saving treatments more accessible and affordable worldwide.

For Feedback, please email us at: communications@mmactiv.com

Sign up here to access BioSpectrum India Flip Book.

Sign up here to access BioSpectrum India Flip Book

Videos

Have an Account?

Forgot your password?

First Name should not be empty!

Last Name should not be empty!

Email address should not be empty!

Show Password should not be empty!

Show Confirm Password should not be empty!

Newsletter

E-magazine

Biospectrum Infomercial

Bio Resource

I accept the terms & conditions & Privacy policy